Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
The Manual for Well known rough terrain Vehicles - 2My Pioneering Excursion: Building a Startup
- 3The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- 4Moon-bound Artemis II astronauts enjoy a relaxed day in space
- 5Emergency services search for five people last seen in missing Jeep
- Alix Earle built trust by sharing her acne woes. Now her skin care line is raising questions.
- Figure out how to Amplify Your Open Record Reward
- 6 Hints to Upgrade Your Appeal, In addition to Your Outlook
- Analysis-NASA's moon mission tests aerospace old guard as SpaceX, Blue Origin hover
- Online business Stages for Little Retailers
- Blue Origin's next space tourism flight will break new ground for people with disabilities
- The most effective method to Guarantee Simple Availability in Seniors' SUVs
- Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
- Airport wait times won't return to normal until Congress reaches a deal to pay TSA. Here's why they still can't come to an agreement.
